Disseminated tumor cells in lymph nodes as a determinant for survival in surgically resected non-small-cell lung cancer

Journal of Clinical Oncology

Volumn 17, Issue 1, 1999, Pages 19-24

  Kubuschok, B ^a   Passlick, B ^a   Izbicki, J R ^a   Thetter, O ^a   Pantel, K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN 17 1A; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY BER EP4; UNCLASSIFIED DRUG;

ARTICLE; CANCER RISK; CANCER SURVIVAL; CONTROLLED STUDY; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; PROGNOSIS; RECURRENCE RISK;

EID: 0032928142     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/jco.1999.17.1.19     Document Type: Article

References (29)

1. Pantel K, Riethmüller G: Micrometastasis detection and treatment with monoclonal antibodies. Curr Top Microbiol Immunol 213:1-18, 1996 (part 3)
2. Naruke T, Goya T, Tsuchiya R, et al: Prognosis and survival in resected lung cancer based on the new international staging system. J Thorac Cardiovasc Surg 96:440-447, 1988
3. Ginsberg RJ, Yokes EE, Raben AL: Non-small cell lung cancer, in De Vita VT Jr, Hellmann S, Rosenberg SA (eds): Cancer: Principles & Practice of Oncology (ed 5). Philadelphia, PA, Lippincott, 1997, pp 858-911
4. Passlick B, Izbicki JR, Kubuschok B, et al: Immunohistochemical assessment of individual tumor cells in lymph nodes of patients with non-small-cell lung cancer. J Clin Oncol 12:1827-1832, 1994
5. Chen Z-L, Perez S, Holmes EC, et al: Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma. J Natl Cancer Inst 85:439-489, 1993
6. Maruyama R, Sugio K, Mitsudomi T, et al: Relationship between early recurrence and micrometastases in the lymph nodes of patients with stage I non-small-cell lung cancer. J Thorac Cardiovasc Surg 114:535-543, 1997
7. Pantel K, Izbicki JR, Passlick B, et al: Frequency and prognostic significance of isolated tumor cells in bone marrow of patients with non-small-cell lung cancer without overt metastases. Lancet 347:649-653, 1996
8. Ohgami A, Mitsudomi T, Sugio K, et al: Micrometastatic tumor cells in the bone marrow of patients with non-small cell lung cancer. J Thorac Cardiovasc Surg 64:363-367, 1997
9. Cote RJ, Beattie EJ, Chaiwun B, et al: Detection of occult bone marrow micrometastases in patients with operable lung carcinoma. Ann Surg 222:415-425, 1995
10. de Mascarel I, Bonichon F, Coindre J, et al: Prognostic significance of breast cancer micrometastasis assessed by two special techniques: Reevaluation and longer follow-up. Br J Cancer 66:523-527, 1992
11. McGuckin MA, Cummings MC, Walsh MD, et al: Occult axillary node metastases in breast cancer: Their detection and prognostic significance. Br J Cancer 73:88-95, 1996
12. Galea MH, Athanassiou E, Bell J, et al: Occult regional lymph node metastases from breast carcinoma: Immunohistochemical detection with antibodies CAM 5.2 and NCRC-11. J Pathol 165:221-227, 1991
13. Greenson JK, Isenhart CE, Rice R, et al: Identification of occult micrometastasis in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49: Correlation with long-term survival. Cancer 73:563-569, 1994
14. Jeffers M, O'Dowd G, Mulcahey H, et al: The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma. J Pathol 172:183-187, 1994
15. Hermanek P, Sobin LH (eds): TNM classification of malignant tumours (ed 4, rev 2). New York, Springer, 1992
16. Martini N, Flehinger BJ, Zaman MB, et al: Results of resection in non-oat cell carcinoma of the lung with mediastinal lymph node metastasis. Ann Surg 198:386-397, 1983
17. Latza U, Niedobitek G, Schwarting R, et al: Ber-Ep4: New monoclonal antibody which distinguishes epithelia from mesothelia. J Clin Pathol 43:213-219, 1990
18. Litvinov S, Velders M, Bakker H, et al: Ep-CAM: A human epithelial antigen is a homophilic cell-cell adhesion molecule. J Cell Biol 125:437-446, 1994
19. Göttlinger HG, Funke I, Johnson JF, et al: The epithelial suface antigen 17-1A, a target for antibody-mediated tumor-therapy: Its biochemical nature, tissue distribution and recognition by different antibodies. Int J Cancer 38:47-53, 1986
20. Gould V, Warren W, Faber L, et al: Malignant cells of epithelial phenotype limited to thoracic lymph nodes. Eur J Cancer 26:1121-1126, 1990
21. Dobashi K, Sugio K, Osaki T, et al: Micrometastatic p53-positive cells in the lymph nodes of non-small cell lung cancer: Prognostic significance. J Thorac Cardiovasc Surg 114:339-346, 1997
22. Hayashi N, Ito I, Yanagisawa A, et al: Genetic diagnosis of lymph-node metastasis in colorectal cancer. Lancet 345:1257-1259, 1995
23. Passlick B, Izbicki JR, Kubuschok B, et al: Detection of disseminated lung cancer cells in lymph nodes: Impact on staging and prognosis. Ann Thorac Surg 61:177-183, 1996
24. Pantel K, Schlimok G, Braun S, et al: Differential expression of proliferation-associated molecules in individual micrometastatic carcinoma cell. J Natl Cancer Inst 85:1419-1424, 1993
25. Demicheli R, Terenziani M, Valagussa P, et al: Local recurrences following mastectomy: Support for the concept of tumor dormancy. J Natl Cancer Inst 86:45-48, 1994
26. Liefers G-J, Cleton-Jansen A-M, van de Velde CJH, et al: Micrometastases and survival in stage II colorectal cancer. N Engl J Med 339:223-228, 1998
27. Zippelius A, Kufer P, Honold G, et al: Limitations of reverse-transcriptase polymerase chain reaction analyses for detection of micrometastatic epithelial cancer cells in bone marrow. J Clin Oncol 15:2701-2708, 1997
28. Krismann M, Todt B, Schröder J, et al: Low specifity of cytokeratin 19 reverse transcriptase-polymerase chain reaction analyses for detection of hematogenous lung cancer dissemination. J Clin Oncol 13:2769-2775, 1995
29. Riethmüller G, Holz E, Schlimok G, et al: Monoclonal antibody therapy for resected Dukes's C colorectal carcinoma: Seven year outcome of a multicenter randomized trial. J Clin Oncol 16:1788-1794, 1998